Magnetic Resonance Imaging
Volume 28, Issue 2 , Pages 163-170 , February 2010

MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis

  • Radhika Srinivasan

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94107-1739, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 415 514 4426; fax: +1 415 514 2550.
    • ,
  • Helene Ratiney

      Affiliations

    • Université de Lyon, CREATIS-LRMN; CNRS UMR 5220, Inserm U630, INSA-Lyon, Université Lyon 1, Villeurbanne, France
    • ,
  • Kathyrn E. Hammond-Rosenbluth

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94107-1739, USA
    • ,
  • Daniel Pelletier

      Affiliations

    • Department of Neurology, University of California, San Francisco, CA 94143-0435, USA
    • ,
  • Sarah J. Nelson

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94107-1739, USA

Received 20 January 2009 ,Revised 26 May 2009 ,Accepted 25 June 2009.

References 

  1. Terpstra M, Henry PG, Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med. 2003;50(1):19–23
  2. Otazo R, Mueller B, Ugurbil K, Wald L, Posse S. Signal-to-noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo-planar spectroscopic imaging. Magn Reson Med. 2006;
  3. Srinivasan R, Vigneron D, Napapon S, Hurd R, Nelson S. A comparative study of myo-inositol quantification using LCmodel at 1.5T and 3.0T with 3D 1H proton spectroscopic imaging of the human brain. MRI. 2004;51(3):435–446
  4. Tkac I, Oz G, Gruetter R. In: Comparison of metabolite quantification in the human brain at 4 and 7 Tesla. Proceedings for the International Society of Magnetic Resonance in Medicine. 2005;p. 2458;[Miami]
  5. Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem. 2003;384(4):505–516
  6. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61(3):154–166
  7. Mann CL, Davies MB, Boggild MD, Alldersea J, Fryer AA, Jones PW, et al. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology. 2000;54(3):552–557
  8. Tajouri L, Mellick AS, Ashton KJ, Tannenberg AE, Nagra RM, Tourtellotte WW, et al. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res. 2003;119(2):170–183
  9. Frade J, Pope S, Schmidt M, Dringen R, Barbosa R, Pocock J, et al. Glutamate induces release of glutathione from cultured rat astrocytes — a possible neuroprotective mechanism?. J Neurochem. 2008;
  10. Starlack J, Nelson S, Kurhanewicz J, Huang LR, Vigneron D. Improved water and Lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med. 1997;38(2):311–321
  11. Hammond K, Lupo J, Kelley D, Nelson S. In: Comparison of the B0 field and shimming in human brains at 3T and 7T. Proceedings for the International Society of Magnetic Resonance in Medicine. 2006;p. 2352;[Seattle]
  12. Stollberger R, Wach P. Imaging of the active B1 field in vivo. Magn Reson Med. 1996;35(2):246–251
  13. Pauly J, Le Roux P, Nishimura D, Macovski A. Parameter relations for Shinnar–Le Roux selective excitation pulse design algorithm. IEEE Trans Med Imaging. 1991;10:56–65
  14. Moonen C, Van Zijl P. Highly effective water suppression for in-vivo. J Magn Reson. 1990;88:28–41
  15. Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med. 2001;46(2):228–239
  16. Osorio JA, Ozturk-Isik E, Xu D, Cha S, Chang S, Berger MS, et al. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil. J Magn Reson Imaging. 2007;26(1):23–30
  17. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med. 1999;42(5):952–962
  18. Pijnappel WWF, Boogaart Vd, Beer RD, Ormondt DV. SVD-based quantification of magnetic resonance signals. JMagn Reson. 1992;97:122–134
  19. Smith S. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–155
  20. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001;20:45–57
  21. Hetherington HP, Pan JW, Mason GF, Adams D, Vaughn MJ, Twieg DB, et al. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med. 1996;36(1):21–29
  22. Snyder J, Thompson RB, Wild JM, Wilman AH. Strongly coupled versus uncoupled spin response to radio frequency interference effects: application to glutamate and glutamine in spectroscopic imaging. NMR Biomed. 2007;21(4):402–409
  23. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson. 2001;153:155–177
  24. McNab JA, Bartha R. Quantitative short echo-time 1H LASER-CSI in human brain at 4 T. NMR Biomed. 2006;19(8):999–1009
  25. Wright PJ, Mougin OE, Totman JJ, Peters AM, Brookes MJ, Coxon R, et al. (1) measurements in brain tissue at 7, 3, and 1.5T using IR-EPI, IR-TSE, and MPRAGE: results and optimization. Magma. 2008;21(1-2):121–130
  26. Srinivasan R, Cunningham C, Chen A, Vigneron D, Hurd R, Nelson S, et al. TE-averaged two- dimensional proton spectroscopic imaging of glutamate at 3 T. Neuroimage. 2006;30(4):1171–1178
  27. Cooper A. Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress. In:  Shaw CA editors. Glutathione in the nervous system. London: Taylor and Francis; 1998;p. 91–115
  28. Sasaki T, Senda M. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO. J Nucl Med. 1999;40(6):1056–1060
  29. Bongarzone ER, Pasquini JM, Soto EF. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res. 1995;41(2):213–221
  30. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993;151(4):2132–2141
  31. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci. 2000;177(2):95–103
  32. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain. 1999;122(Pt 1):17–26
  33. Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain. 2002;125(Pt 2):327–337
  34. Audoin B, Davies GR, Finisku L, Chard DT, Thompson AJ, Miller DH. Localization of grey matter atrophy in early RRMS: a longitudinal study. J Neurol. 2006;253(11):1495–1501
  35. Mohamed A, Shoker A, Bendjelloul F, Mare A, Alzrigh M, Benghuzzi H, et al. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed Sci Instrum. 2003;39:440–445

PII: S0730-725X(09)00170-2

doi: 10.1016/j.mri.2009.06.008

Magnetic Resonance Imaging
Volume 28, Issue 2 , Pages 163-170 , February 2010

Article Tools

* Image Usage & Resolution